https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/accrued-rent-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/accrued-rent-current-and-noncurrent https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/accrued-rent-noncurrent https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/accrued-royalties-current-and-noncurrent https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/accumulated-oci-foreign-currency-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/advertising-expense https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/amended-reports-10-k https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/amended-reports-10-q https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/amortization https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/available-for-sale-change-in-net-unrealized-holding-gain-loss https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/available-for-sale-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/available-for-sale-gross-unrealized-gain https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/available-for-sale-gross-unrealized-gains https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/available-for-sale-gross-unrealized-losses https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/buybacks-payments-for-hedge-financing-activities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/capital-lease-obligations https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/construction-in-progress-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/construction-in-progress-gross https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/contractual-obligation-due-in-fourth-year https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/contractual-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/contractual-obligation-due-in-second-year https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/contractual-obligation-due-in-third-year https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/convertible-debt-fair-value-disclosures https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/convertible-debt-noncurrent https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/convertible-notes-payable https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/cost-of-goods-sold https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/customer-advances-and-deposits https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/customer-advances-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/customer-deposits-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/debt-and-capital-lease-obligations https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/debt-issuance-costs https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/debt-issued https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/debt-repaid https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-compensation-arrangement-with-individual-compensation-expense https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-compensation-liability-classified-noncurrent https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-compensation-liability-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-revenue-2 https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-revenue-additions https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-revenue-and-credits-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-general-business https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/deferred-tax-liabilities-unrealized-currency-transaction-gains https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-accumulated-benefit-obligation https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-accumulated-oci-minimum-pension-liability-after-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-actual-return-on-plan-assets https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-actuarial-gain-loss https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-amortization-of-prior-service-cost-credit https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-assumptions-used-calculating-benefit-obligation-discount-rate https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-assumptions-used-calculating-benefit-obligation-rate-of-compensation-increase https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-assumptions-used-calculating-net-periodic-benefit-cost-discount-rate https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-assumptions-used-calculating-net-periodic-benefit-cost-expected-long-term-return-on-assets https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-assumptions-used-calculating-net-periodic-benefit-cost-rate-of-compensation-increase https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-benefit-obligation https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-benefits-paid https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-contributions-by-employer https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-contributions-by-plan-participants https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-expected-future-benefit-payments-five-fiscal-years-thereafter https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-expected-future-benefit-payments-next-twelve-months https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-expected-future-benefit-payments-year-five https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-expected-future-benefit-payments-year-four https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-expected-future-benefit-payments-year-three https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-expected-future-benefit-payments-year-two https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-expected-return-on-plan-assets https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-fair-value-of-plan-assets https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-foreign-currency-exchange-rate-changes-benefit-obligation https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-foreign-currency-exchange-rate-changes-plan-assets https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-future-amortization-of-prior-service-cost-credit https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-interest-cost https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-net-periodic-benefit-cost https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-pension-plans-with-accumulated-benefit-obligations-in-excess-of-plan-assets-aggregate-accumulated-benefit-obligation https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-pension-plans-with-accumulated-benefit-obligations-in-excess-of-plan-assets-aggregate-fair-value-of-plan-assets https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-pension-plans-with-accumulated-benefit-obligations-in-excess-of-plan-assets-aggregate-projected-benefit-obligation https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-service-cost https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-settlements-benefit-obligation https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plan-settlements-plan-assets https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plans-estimated-future-employer-contributions-in-current-fiscal-year https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/defined-benefit-plans-estimated-future-employer-contributions-in-next-fiscal-year https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/derivative-financial-instruments-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/disposal-group-including-discontinued-operation-cash-and-cash-equivalents https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/disposal-group-including-discontinued-operation-foreign-currency-translation-gains-losses https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/disposal-group-not-discontinued-operation-gain-loss-on-disposal https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/equity-issuance-per-share-amount https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/equity-method-investments https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/finite-lived-intangible-assets-useful-life-maximum https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/finite-lived-intangible-assets-weighted-average-useful-life https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/foreign-currency-transaction-gain-before-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/foreign-currency-transaction-loss-before-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/foreign-pretax-income https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/future-amortization-expense-after-year-five https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/future-amortization-expense-year-five https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/future-amortization-expense-year-four https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/future-amortization-expense-year-one https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/future-amortization-expense-year-three https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/future-amortization-expense-year-two https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/future-minimum-sublease-rentals-sale-leaseback-transactions-within-one-year https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/gain-or-loss-on-sale-of-stock-in-subsidiary https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/income-tax-expense-benefit-intraperiod-tax-allocation https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/increase-decrease-in-other-accrued-liabilities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/increase-decrease-in-other-current-liabilities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/increase-decrease-in-receivables https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/incremental-common-shares-attributable-to-conversion-of-debt-securities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/insider-transactions-corporate-securities/purchases https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/interest-on-convertible-debt-net-of-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/inventory-adjustments https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/inventory-finished-goods https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/inventory-gross https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/inventory-noncurrent https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/inventory-raw-materials https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/inventory-work-in-process https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/inventory-write-down https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/letters-of-credit-outstanding-amount https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/liability-for-uncertain-tax-positions-noncurrent https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/license-costs https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/licenses-revenue https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/loans-payable-to-bank https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/loans-payable-to-bank-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/long-term-debt https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/long-term-debt-and-capital-lease-obligations https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/long-term-debt-and-capital-lease-obligations-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/long-term-loans-from-bank https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/marketable-securities-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/notes-payable-to-bank-noncurrent https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/oci-amortization-adjustment-from-aoci-pension-and-other-postretirement-benefit-plans-for-net-prior-service-cost-credit-net-of-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/oci-amortization-adjustment-from-aoci-pension-and-other-postretirement-benefit-plans-for-net-prior-service-cost-credit-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/oci-available-for-sale-adjustment-net-of-tax-change https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/oci-before-reclassifications-net-of-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/oci-defined-benefit-plans-adjustment-net-of-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/oci-defined-benefit-plans-net-unamortized-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/oci-foreign-currency-translation-gain-loss-arising-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/oci-net-of-tax-2 https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/oci-net-of-tax-change https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/oci-pension-and-other-postretirement-benefit-plans-adjustment-net-of-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/oci-pension-and-other-postretirement-benefit-plans-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-net-of-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/operating-leases-rent-expense-sublease-rentals https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/other-assets https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/other-current-assets https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/other-current-liabilities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/other-long-term-debt-noncurrent https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/other-sundry-liabilities-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/paid-in-capital-equity-component-of-convertible-debt https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/paid-in-kind-interest https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/patents-active https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/patents-rejected https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/payments-for-restructuring https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/payments-to-acquire-productive-assets https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/pretax-income-domestic https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/prior-period-reclassification-adjustment https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/proceeds-from-divestiture-of-interest-in-consolidated-subsidiaries https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/proceeds-from-income-tax-refunds https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/proceeds-from-repayments-of-long-term-debt-and-capital-securities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/proceeds-from-sale-of-equity-method-investments https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/property-plant-and-equipment-useful-life-maximum https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/property-plant-and-equipment-useful-life-minimum https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/receivables-net-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/reclassification-from-accumulated-oci-current-period-net-of-tax https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/reclassification-from-aoci-current-period-net-of-tax-attributable-to-parent https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/recognition-of-deferred-revenue https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/restructuring-and-related-cost-number-of-positions-eliminated https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/restructuring-charges https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/restructuring-reserve https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/restructuring-reserve-accrual-adjustment https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/restructuring-reserve-accrual-adjustment-1 https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/restructuring-reserve-current https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sales-returns-and-allowances-goods https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-10-k405 https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-15-12b https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-15-12g https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-ars https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-ct-order https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-no-act https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-regdex https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-sc-14d9 https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-sc-to-c https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-sc-to-t https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sec-filings-sc14d9c https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/secondary-offerings-form-aw https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/secondary-offerings-form-pos462b https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/severance-costs https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/share-price https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/square-footage-of-real-estate-property https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-payments https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-term https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-award-rsu-forfeited-in-period-grant-date-fair-value https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-exercisable-remaining-term https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-outstanding-remaining-term https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-remaining-term https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/supplemental-deferred-purchase-price https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/utb-resulting-in-net-operating-loss-carryforward https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/valuation-allowances-and-reserves-adjustments https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/valuation-allowances-and-reserves-balance https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/valuation-allowances-and-reserves-deductions https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/ariad-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted